Abstract: The present invention is directed to the TVEMF-expansion of mammalian blood stem cells, preferably CD34+/CD38? cells, to compositions resulting from the TVEMF-expanded cells, and to a method of treating disease or repairing tissue with the compositions.

Abstract: The present invention is directed to the TVEMF-expansion of mammalian peripheral blood stem cells, preferably CD34+/CD38? cells, to compositions resulting from the TVEMF-expanded cells, and to a method of treating disease or repairing tissue with the compositions.

Abstract: The present invention is directed to the TVEMF-expansion of mammalian blood stem cells, preferably CD34+/CD38? cells, to compositions resulting from the TVEMF-expanded cells, and to a method of treating heart disease or repairing heart tissue with the compositions.

Abstract: The present invention is directed to the TVEMF-expansion of mammalian blood stem cells, preferably CD34+/CD38? cells, to compositions resulting from the TVEMF-expanded cells, and to a method of treating a disease or condition or repairing tissue of skin, mouth or ear with the compositions.

Abstract: The present invention is directed to the TVEMF-expansion of mammalian cord blood stem cells, preferably CD34+/CD38? cells, to compositions resulting from the TVEMF-expanded cells, and to a method of treating disease or repairing tissue with the compositions. Various benefits and advantages to the compositions of the present invention are discussed herein.

Abstract: Disclosed herein is a method of replenishing cells damaged by treatment for cancer. The method comprises removing blood cells from a primate mammal, controllably expanding the cells at a rate which produces an expansion factor of at least 700% within 7 days while maintaining their three-dimensional geometry and their cell-to-cell support and cell-to-cell geometry, removing any toxic materials from the blood cells, and reintroducing the cells into the primate mammal within a time period sufficient to prevent the primate mammal from suffering decreased mobility due to loss of hematopoietic or other cells.

Abstract: A method for regenerating a human individual's tissue is disclosed comprising determining the white blood cell content of the individual, administering granulocyte colony-stimulating factor to the individual while monitoring the white blood cell content of the individual, continuing the administration of the granulocyte colony-stimulating factor to the individual until the white blood cell content is more than twice its original amount, maintaining the administration of the granulocyte colony-stimulating factor to the individual at a level that maintains the white blood cell content at least at twice its original amount, monitoring the individual's tissue to be regenerated, and discontinuing the administration of the granulocyte colony-stimulating factor to the individual when the tissue regenerates.

Abstract: A method of repairing primate mammalian tissue is disclosed, with the method comprising removing blood cells from the primate mammal, controllably expanding the blood cells by a factor of at least seven times preferably in less than seven days while maintaining their three-dimensional geometry and their cell-to-cell support and cell-to-cell geometry, and reintroducing the expanded blood cells into the primate mammal within a time period sufficient to allow the primate mammal body system to utilize the blood cells to effectively repair damaged tissue.

Abstract: A method of repairing primate mammalian tissue is disclosed, with the method comprising removing blood cells from the primate mammal, controllably expanding the blood cells by a factor of at least seven times preferably in less than seven days while maintaining their three-dimensional geometry and their cell-to-cell support and cell-to-cell geometry, and reintroducing the expanded blood cells into the primate mammal within a time period sufficient to allow the primate mammal body system to utilize the blood cells to effectively repair damaged tissue.

Abstract: Disclosed herein is a method of replenishing cells damaged by treatment for cancer. The method comprises removing blood cells from a primate mammal, controllably expanding the cells at a rate which produces an expansion factor of at least 700% within 7 days while maintaining their three-dimensional geometry and their cell-to-cell support and cell-to-cell geometry, removing any toxic materials from the blood cells, and reintroducing the cells into the primate mammal within a time period sufficient to prevent the primate mammal from suffering decreased mobility due to loss of hematopoletic or other cells.

Abstract: A method for regenerating a human individual's tissue is disclosed comprising determining the white blood cell content of the individual, administering granulocyte colony-stimulating factor to the individual while monitoring the white blood cell content of the individual, continuing the administration of the granulocyte colony-stimulating factor to the individual until the white blood cell content is more than twice its original amount, maintaining the administration of the granulocyte colony-stimulating factor to the individual at a level that maintains the white blood cell content at least at twice its original amount, monitoring the individual's tissue to be regenerated, and discontinuing the administration of the granulocyte colony-stimulating factor to the individual when the tissue regenerates.